Citable segment mix
BIIB's latest SEC segment disclosure for revenue by product shows Product revenue, net as the largest listed segment at $1.92B (70.0% of disclosed segment revenue).
| Segment | Period | Revenue | Mix |
|---|---|---|---|
| Product revenue, net | Jun 30, 2026 | $1.92B | 70.0% |
| Revenue from anti-CD20 therapeutic programs | Jun 30, 2026 | $513.50M | 18.8% |
| Contract manufacturing, royalty and other revenue | Jun 30, 2026 | $242.40M | 8.9% |
| Alzheimer's collaboration revenue | Jun 30, 2026 | $63.70M | 2.3% |
Source: SEC EDGAR segment disclosures; period Jun 30, 2026.
BIIB company research is available with Aerarium Pro (CAD $10/mo). The five showcase tickers (TSLA, NVDA, AAPL, AMZN, PLTR) and the macro dashboard stay free. Already a subscriber? Sign in to pick up where you left off.